Home » Topics » Regulatory » Patents

Patents
RSS

SKB reveals selective inhibitors of bacterial enzyme

Dec. 5, 1997

DuPont Merck develops novel CRF antagonists

Dec. 5, 1997

Vitronectin receptor antagonists described by Hoechst

Dec. 4, 1997

Bayer develops CETP inhibitors

Dec. 4, 1997

Diagnostic use of specific sigma2 ligands described by Wake Forest University

Dec. 4, 1997

MDR modulators prepared at Janssen

Dec. 4, 1997

Antiviral thiazolidines and thiazolidinones from INSERM

Dec. 4, 1997

Neurogen patents new dopamine receptor subtype-specific ligands

Dec. 3, 1997

VEGF receptor tyrosine kinase inhibitors under development at Zeneca

Dec. 3, 1997

Compounds for 5-HT-mediated disorders from Astra

Dec. 3, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...